Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS 37779 cream in chronic plaque psoriasis
2005-003162-42Phase 2Completed
- Sponsor
- Almirall
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of LAS37779 in psoriasis (2 arms), sponsored by Almirall. Primary endpoint: Efficacy of 1% LAS 37779 cream versus vehicle after 4 weeks. Started Aug 2005; status: completed.
02
Drugs
LAS37779
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2005-003162-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003162-42.